Pomanda estimates the enterprise value of STERIVACUK LIMITED at £5.8m based on a Turnover of £5.8m and 1x industry multiple (adjusted for size and gross margin).
sterivacuk limitedEstimated Valuation
£5m
Pomanda estimates the enterprise value of STERIVACUK LIMITED at £5m based on an EBITDA of £875.4k and a 5.68x industry multiple (adjusted for size and gross margin).
sterivacuk limitedEstimated Valuation
£7.3m
Pomanda estimates the enterprise value of STERIVACUK LIMITED at £7.3m based on Net Assets of £3.7m and 1.97x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sterivacuk LimitedOverview
Sterivacuk Limited is a live company located in london, WC1H 9HR with a Companies House number of 03263925. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in October 1996, it's largest shareholder is
sterivac ltd
with a 100% stake. Sterivacuk Limited is a mature,
mid sized company, Pomanda has estimated its turnover at
£5.8m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Sterivacuk Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
5 Strong
5 Regular
2 Weak
Size
annual sales of £5.8m, make it smaller than the average company (£12.3m)
£5.8m - Sterivacuk Limited
£12.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (5.6%)
5% - Sterivacuk Limited
5.6% - Industry AVG
Production
with a gross margin of 38.9%, this company has a comparable cost of product (38.9%)
38.9% - Sterivacuk Limited
38.9% - Industry AVG
Profitability
an operating margin of 8.5% make it more profitable than the average company (6.3%)
8.5% - Sterivacuk Limited
6.3% - Industry AVG
Employees
with 57 employees, this is similar to the industry average (61)
57 - Sterivacuk Limited
61 - Industry AVG
Pay Structure
on an average salary of £42.8k, the company has an equivalent pay structure (£42.8k)
£42.8k - Sterivacuk Limited
£42.8k - Industry AVG
Efficiency
resulting in sales per employee of £102.3k, this is less efficient (£140.4k)
£102.3k - Sterivacuk Limited
£140.4k - Industry AVG
Debtor Days
it gets paid by customers after 61 days, this is near the average (53 days)
61 days - Sterivacuk Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 67 days, this is slower than average (37 days)
67 days - Sterivacuk Limited
37 days - Industry AVG
Stock Days
it holds stock equivalent to 38 days, this is less than average (81 days)
38 days - Sterivacuk Limited
81 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 99 weeks, this is more cash available to meet short term requirements (11 weeks)
99 weeks - Sterivacuk Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 24.3%, this is a lower level of debt than the average (46.6%)
24.3% - Sterivacuk Limited
46.6% - Industry AVG
STERIVACUK LIMITED financials
EXPORT
Sterivacuk Limited's latest turnover from October 2018 is estimated at £5.8 million and the company has net assets of £3.7 million. According to their latest financial statements, Sterivacuk Limited has 57 employees and maintains cash reserves of £2 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Oct 2018
Oct 2017
Oct 2016
Oct 2015
Oct 2014
Oct 2013
Oct 2012
Oct 2011
Oct 2010
Oct 2009
Turnover
5,832,650
5,197,143
4,516,231
4,974,340
4,826,043
5,031,610
3,988,526
3,615,245
3,562,570
Other Income Or Grants
Cost Of Sales
3,563,408
3,183,114
2,565,286
2,859,288
2,840,637
3,039,000
2,356,960
2,150,000
2,076,662
Gross Profit
2,269,242
2,014,028
1,950,946
2,115,053
1,985,406
1,992,610
1,631,567
1,465,245
1,485,908
Admin Expenses
1,774,604
1,530,585
1,807,347
1,775,642
1,706,792
1,798,102
1,288,365
1,173,959
969,156
-1,052,447
Operating Profit
494,638
483,443
143,599
339,411
278,614
194,508
343,202
291,286
516,752
1,052,447
Interest Payable
Interest Receivable
13,641
3,406
2,639
4,353
3,682
4,008
3,750
3,252
4,170
2,548
Pre-Tax Profit
508,279
486,849
146,238
343,764
282,296
198,516
346,953
294,538
520,922
1,054,996
Tax
-96,573
-92,501
-29,247
-68,753
-59,282
-45,659
-83,269
-76,580
-145,858
-295,399
Profit After Tax
411,706
394,348
116,990
275,011
223,014
152,857
263,684
217,958
375,064
759,597
Dividends Paid
Retained Profit
411,706
394,348
116,990
275,011
223,014
152,857
263,684
217,958
375,064
759,597
Employee Costs
2,437,344
2,285,355
1,902,364
1,811,392
1,278,481
1,334,840
1,103,887
977,472
1,086,393
Number Of Employees
57
56
50
50
35
38
32
29
32
EBITDA*
875,390
881,146
518,092
697,934
603,278
466,833
599,221
532,366
739,186
1,258,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Oct 2018
Oct 2017
Oct 2016
Oct 2015
Oct 2014
Oct 2013
Oct 2012
Oct 2011
Oct 2010
Oct 2009
Tangible Assets
1,403,010
1,388,583
1,470,376
1,488,817
1,322,207
1,102,074
938,887
1,047,623
1,079,285
1,056,595
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
1,403,010
1,388,583
1,470,376
1,488,817
1,322,207
1,102,074
938,887
1,047,623
1,079,285
1,056,595
Stock & work in progress
376,601
345,258
308,703
285,188
382,880
355,494
325,978
330,826
283,653
334,416
Trade Debtors
987,749
854,344
776,221
880,889
965,650
914,809
735,996
631,232
610,433
539,634
Group Debtors
Misc Debtors
105,597
103,350
178,297
102,132
Cash
1,999,811
1,637,702
1,087,431
1,023,400
717,717
754,983
848,063
652,107
648,605
1,019,377
misc current assets
total current assets
3,469,758
2,940,654
2,350,652
2,291,609
2,066,247
2,025,286
1,910,037
1,614,165
1,542,691
1,893,427
total assets
4,872,768
4,329,237
3,821,028
3,780,426
3,388,454
3,127,360
2,848,924
2,661,788
2,621,976
2,950,022
Bank overdraft
Bank loan
Trade Creditors
659,137
516,958
487,135
502,059
773,530
773,152
666,654
731,763
786,424
624,225
Group/Directors Accounts
13,748
36,971
23,887
24,831
other short term finances
hp & lease commitments
other current liabilities
376,507
357,110
273,852
306,271
total current liabilities
1,049,392
911,039
784,874
833,161
773,530
773,152
666,654
731,763
786,424
624,225
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
125,000
provisions
133,147
139,675
151,979
180,080
122,750
85,048
65,967
77,406
75,891
66,200
total long term liabilities
133,147
139,675
151,979
180,080
122,750
85,048
65,967
77,406
200,891
66,200
total liabilities
1,182,539
1,050,714
936,853
1,013,241
896,280
858,200
732,621
809,169
987,315
690,425
net assets
3,690,229
3,278,523
2,884,175
2,767,185
2,492,174
2,269,160
2,116,303
1,852,619
1,634,661
2,259,597
total shareholders funds
3,690,229
3,278,523
2,884,175
2,767,185
2,492,174
2,269,160
2,116,303
1,852,619
1,634,661
2,259,597
Oct 2018
Oct 2017
Oct 2016
Oct 2015
Oct 2014
Oct 2013
Oct 2012
Oct 2011
Oct 2010
Oct 2009
Operating Activities
Operating Profit
494,638
483,443
143,599
339,411
278,614
194,508
343,202
291,286
516,752
1,052,447
Depreciation
380,752
397,703
374,493
358,523
324,664
272,325
256,019
241,080
222,434
205,553
Amortisation
Tax
-96,573
-92,501
-29,247
-68,753
-59,282
-45,659
-83,269
-76,580
-145,858
-295,399
Stock
31,343
36,555
23,515
-97,692
27,386
29,516
-4,848
47,173
-50,763
334,416
Debtors
135,652
3,176
-28,503
17,371
50,841
178,813
104,764
20,799
70,799
539,634
Creditors
142,179
29,823
-14,924
-271,471
378
106,498
-65,109
-54,661
162,199
624,225
Accruals and Deferred Income
19,397
83,258
-32,419
306,271
Deferred Taxes & Provisions
-6,528
-12,304
-28,101
57,330
37,702
19,081
-11,439
1,515
9,691
66,200
Cash flow from operations
766,870
849,691
418,389
801,632
503,849
338,424
339,488
334,668
745,182
778,976
Investing Activities
capital expenditure
-395,179
-315,910
-356,052
-525,133
-544,797
-435,512
-147,283
-209,418
-245,124
-1,262,148
Change in Investments
cash flow from investments
-395,179
-315,910
-356,052
-525,133
-544,797
-435,512
-147,283
-209,418
-245,124
-1,262,148
Financing Activities
Bank loans
Group/Directors Accounts
-23,223
13,084
-944
24,831
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
-125,000
125,000
share issue
-1,000,000
1,500,000
interest
13,641
3,406
2,639
4,353
3,682
4,008
3,750
3,252
4,170
2,548
cash flow from financing
-9,582
16,490
1,695
29,184
3,682
4,008
3,750
-121,748
-870,830
1,502,548
cash and cash equivalents
cash
362,109
550,271
64,031
305,683
-37,266
-93,080
195,956
3,502
-370,772
1,019,377
overdraft
change in cash
362,109
550,271
64,031
305,683
-37,266
-93,080
195,956
3,502
-370,772
1,019,377
sterivacuk limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for sterivacuk limited. Get real-time insights into sterivacuk limited's credit score, group structure and payment trends.
Perform a competitor analysis for sterivacuk limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in WC1H area or any other competitors across 12 key performance metrics.
griffins tavistock house north, tavistock square, london, WC1H 9HR
Bank
HSBC BANK PLC
Legal Advisor
-
sterivacuk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to sterivacuk limited. Currently there are 1 open charges and 0 have been satisfied in the past.
sterivacuk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for STERIVACUK LIMITED. This can take several minutes, an email will notify you when this has completed.
sterivacuk limitedCompanies House Filings - See Documents
